Malignant rectal melanoma – a rare case study and literature review
Malígny melanóm konečníka – zriedkavá kazuistika a prehľad literatúry
Primárny malígny melanóm konečníka je extrémne zriedkavé ochorenie prejavujúce sa krvácaním z konečníka. Diagnóza sa stanoví endoskopicky a potvrdí histologicky. Ochorenie býva častokrát diagnostikované až v pokročilom stave. Liečba je najmä chirurgická, avšak o rozsahu výkonu sa neustále diskutuje. Vzhľadom na výskyt len niekoľkých prípadov je optimálny menežment tohoto ochorenia nejednoznačný. V našom článku prezentujeme prípad 55-ročnej ženy s malígnym melanómom konečníka a ponúkame prehľad uvedenej problematiky v literatúre.
Kľúčové slová:
malígny melanóm – konečník – rakovina – abdomino-perineálna resekcia – chirurgia
Autor deklaruje, že v souvislosti s předmětem studie nemá žádné komerční zájmy.
Redakční rada potvrzuje, že rukopis práce splnil ICMJE kritéria pro publikace zasílané do biomedicínských časopisů.
Doručeno:
20. 1. 2014
Přijato:
8. 3. 2014
Authors:
R. Duchoň; D. Pinďák; J. Pavlendová; J. Dolník; R. Šucha; M. Tomáš; J. Pechan
Authors place of work:
Department of Surgical Oncology, Slovak Medical University and National Cancer Institute, Bratislava, SR
Published in the journal:
Gastroent Hepatol 2014; 68(2): 154-156
Category:
Gastrointestinální onkologie: kazuistika
Summary
Primary malignant rectal melanoma is an extremely rare disease manifested by rectal bleeding. The diagnosis is established by endoscopy and confirmed by histology. Unfortunately, the disease is often diagnosed in the advanced stage. Treatment is mainly surgical. However, the intervention scope is still under discussion. Given the low occurrence of cases, optimal management of this disease is ambiguous. In this paper we describe the case of a 55-year-old woman with a malignant rectal melanoma and also present the literature review of these issues.
Key words:
malignant melanoma – rectum – cancer – abdominal-perineal resection – surgery
Introduction
Malignant melanoma is a malignant tumour of the pigment cells, melanocytes. The usual location is the skin, but it can also occur in the mucous membranes or in the eye. Malignant change in the structure and propagation of pigment cells causes melanoma. Malignant rectal melanoma was first described by Moore in 1857 [1,2]. Primary malignant rectal melanoma is an extremely rare malignant disease manifested mainly by rectal bleeding, tenesmus, or the sensation of a foreign body in the rectum. Primary rectal melanoma accounts for 1% of all rectal malignancies. The rectum is the third most common location of malignant melanoma occurrence. The highest prevalence of the disease is in women aged 50–60 years [3–5]. In contrast to other forms, malignant rectal melanoma lacks the association with exposure to ultraviolet light. The diagnosis is specified by histology. Due to the occurence of only a few cases, the optimal management of this disease is ambiguous. Treatment is mainly surgical, but the extent of surgical treatment is constantly under discussion. Radiotherapy and chemotherapy used for patients with malignant rectal melanoma are considered to be only palliative. The prognosis is poor due to the fact that the disease is usually diagnosed at an advanced stage. The median survival for patients with malignant rectal melanoma is 24 months with five-year survival of less than 10% [6].
Case study
In our case we have a 55-year-old woman who visited a doctor because she had fresh blood stains in the stool, without any other difficulties, for a month. Per rectum examination: 2 cm elastic tumour growing into the lumen about 2 cm from the anocutaneous line. Colonoscopic examination: grade I haemorrhoidal knots, 2 cm pink smooth polypoid tumour in the anal canal; the rest of the colon – normal finding. A histology specimen was taken during the colonoscopy with the conclusion of amelanotic epithelioid high-risk malignant melanoma. A CT scan revealed pulmonary parenchyma without focal changes; a small hypodense 4 mm nodule in the 8th segment of the liver under the dome of the diaphragm; the retroperitoneum and mesentery without pathologically enlarged lymph nodes (fig. 1); the uterine body bearing a 27 × 24 mm susp. myomatous uterus; a hypodense formation of 24 × 12 mm just above the internal anal canal; around the right parailiac vessels two lymph nodes up to 1 cm, otherwise no other lymphadenopathy (fig. 2). The histology was reviewed by another pathologist with the conclusion of a mucosal malignant melanoma. This was consulted with the oncologist and the surgeon who indicated radical surgery. The patient underwent an abdominoperineal resection and lymphadenectomy with construction of terminal descendent ostomy, hysterectomy with bilateral adnexectomy for uterus myomatosus and resection of the focus in the 8th segment of the liver (fig. 3). Intraoperative ultrasonography was without any other focal changes in the liver. The postoperative healing process was without complications and on the 7th postoperative day the patient was released to outpatient care. The histological findings confirmed the 28 mm nodular amelanotic melanoma in the anal canal, with metastatic melanoma in all lymph nodes, no apparent perinodal promotion and a 4mm metastasis of a malignant melanoma in the liver (fig. 4, 5). A PET scan was performed without findings of the active disease and the patient was recommended radiotherapy of the perineal, pelvic and inguinal areas.
Discussion
Primary anorectal melanoma is a very rare disease with high malignant potential and a very poor prognosis. There are only few references to the disease, mostly as case reports, or as small groups of patients, in literature [1,2]. From 1939 to 1996, 428 patients with primary rectal malignant melanoma [6] have been documented around the world. Primary anorectal melanoma is a disease representing about 1% of all anorectal malignancies. The rectum is the third most common site of malignant melanoma after the incidence of the skin and eye, which represents about 0.2%–3% of all malignant melanomas [5,7]. The disease occurs mostly after forty years of age with the highest incidence between the fifth and the sixth decade, and is predominant in women.
The most common clinical symptoms include: rectal bleeding, tenesmus and the sensation of a foreign body in the rectum. Endoscopy and computed tomography have the most relevant results for diagnosis and staging of the disease [8]. Diagnosis is confirmed by histological and immunohistochemical evidence of melanin, S-100 protein and HMB-45.
The prognosis is poor: five-year survival is given below 5%, and at the time of diagnosis 60% of patients have distant metastasis or lymph node metastasis [9]. Factors involved in the poor prognosis of the disease are: ulceration of the tumour, the biological nature of the tumour, high congestion of rectal mucosa, and hematogenous metastasis [10,11]. Synchronous presence of visceral metastases and pelvic nodal involvement are the results of high metastatic potential.
The only potentially curative modality is surgical resection. The aim of the surgical treatment is to achieve local control and prevention of local recurrence of the disease. There is no consensus as to the extent of surgery. Several studies have considered the method of choice to be abdominoperineal resection with lymphadenectomy [9,12,13]. The principle of this procedure is based on the assumption that the disease has spread beyond the submucosa proximal to the mesenteric lymph nodes. Other studies suggest only restorative sphincter surgery in terms of the wide excision, either in combination with adjuvant radiotherapy to the tumour area and regional pericolic and inguinal lymph nodes, or not [13–15]. Radiotherapy and chemotherapy alone are considered to be only palliative treatment of locally advanced or metastatic colorectal malignant melanoma [15].
Conclusion
Malignant rectal melanoma is a rare disease. Prompt diagnosis and adequate treatment based on a multidisciplinary approach is essential for the prognosis of the patient. Unfortunately it is a disease with high malignant potential, and overall survival of patients with malignant rectal melanoma is low.
The author declares he has no potential conflicts of interest concerning drugs, products, or services used in the study.
The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.
Submitted: 20. 1. 2014
Accepted: 8. 3. 2014
Robert Duchoň, MD
Department of Surgical Oncology
Slovak Medical University and National Cancer Institute
Klenova 1, 833 10 Bratislava
Slovak Republic
robert.duchon@nou.sk
Zdroje
1. Liptrot S, Semeraro D, Ferguson A et al. Malignant melanoma of the rectum: a case report. J Med Case Rep 2009; 3: 9318. doi: 10.1186/1752-1947-3-9318.
2. van Schaik PM, Ernst MF, Meijer HA et al. Melanoma of the rectum: a rare entity. World J Gastroenterol 2008; 14(10): 1633–1635.
3. Kayhan B, Turan N, Ozaslan E et al. A rare entity in the rectum: malignant melanoma. Turk J Gastroenterol 2003; 14(4): 273–275.
4. Roviello F, Cioppa T, Marrelli D et al. Primary ano-rectal melanoma: considerations on a clinical case and review of the literature. Chir Ital 2003; 55(4): 575–580.
5. Takahashi T, Velasco L, Zarate X et al. Anorectal melanoma: report of three cases with extended follow-up. South Med J 2004; 97(3): 311–313.
6. Brady MS, Kavolius JP, Quan SH. Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum 1995; 38(2): 146–151.
7. Solaz Moreno E, Vallalta Morales M, Silla Búrdalo G et al. Primary melanoma of the rectum: an infrequent neoplasia with an atypical presentation. Clin Transpl Oncol 2005; 7(4): 171–173.
8. Kim KW, Ha HK, Kim AY et al. Primary malignant melanoma of the rectum: CT findings in eight patients. Radiology 2004; 232(1): 181–186.
9. Antoniuk PM, Tjandra JJ, Webb BW et al. Anorectal malignant melanoma has a poor prognosis. Int J Colorectal Dis 1993; 8(2): 81–86.
10. Maqbool A, Lintner R, Bokhari A et al. Anorectal melanoma – 3 case reports and review of the literature. Cutis 2004; 73(6): 409–413.
11. Hazzan D, Reissmann P, Halak M et al. Primary rectal malignant melanoma: report of two cases. Tech Coloproctol 2001; 5(1): 51–54.
12. Bhattacharjee PK, Ray D, Ray M et al. Anorectal amelanotic malignant melanoma. Indian J Surg 2003; 65: 370–372.
13. Yap LB, Neary P. A comparison of wide local excision with abdominoperineal resection in anorectal melanoma. Melanoma Res 2004; 14(2): 147–150.
14. Pantalone D, Taruffi F, Paolucci R et al. Malignant melanoma of the rectum. Eur J Surg 2000; 166(7): 583–584.
15. Ballo MT et al. Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol 2002; 20(23): 4555–4558.
Štítky
Detská gastroenterológia Gastroenterológia a hepatológia Chirurgia všeobecnáČlánok vyšiel v časopise
Gastroenterologie a hepatologie
![Číslo 2](https://www.prelekara.sk/media/cache/resolve/journal_issue/media/image_pdf/bea0f207564ee1cf4bb91024527960e0.jpeg)
2014 Číslo 2
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Fixní kombinace paracetamol/kodein nabízí synergické analgetické účinky
- Antidepresivní efekt kombinovaného analgetika tramadolu s paracetamolem
- Kombinace metamizol/paracetamol v léčbě pooperační bolesti u zákroků v rámci jednodenní chirurgie
Najčítanejšie v tomto čísle
- doc. MUDr. Jan Martínek, Ph.D., AGAF (1969)
- MUDr. Sylvia Dražilová (1972)
- MUDr. Ondřej Ryska, Ph.D. (1981)
- Hereditary angioedema as a cause of abdominal pain